|
Restenosis
Citations 181-190 of 538 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Probucol Protects Against Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1
- Yi-Mo Deng, Ben J. Wu, Paul K. Witting, and Roland Stocker
Circulation published September 13, 2004, doi:10.1161/01.CIR.0000142610.10530.25
[Abstract]
- Articles
Estrogen Modulates Inflammatory Mediator Expression and Neutrophil Chemotaxis in Injured Arteries
- Andrew P. Miller, Wenguang Feng, Dongqi Xing, Nathaniel M. Weathington, J. Edwin Blalock, Yiu-Fai Chen, and Suzanne Oparil
Circulation published September 7, 2004, doi:10.1161/01.CIR.0000142050.19488.C7
[Abstract]
- Coronary Heart Disease
Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials
- Donald E. Cutlip, Amit G. Chhabra, Donald S. Baim, Manish S. Chauhan, Sachin Marulkar, Joseph Massaro, Ameet Bakhai, David J. Cohen, Richard E. Kuntz, and Kalon K.L. Ho
Circulation 2004;110:1226-1230; published online before print as doi:10.1161/01.CIR.0000140721.27004.4B
[Abstract]
[Full text]
- Articles
Beyond Restenosis. Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials
- Donald E. Cutlip, Amit G. Chhabra, Donald S. Baim, Manish S. Chauhan, Sachin Marulkar, Joseph Massaro, Ameet Bakhai, David J. Cohen, Richard E. Kuntz, and Kalon K.L. Ho
Circulation published August 30, 2004, doi:10.1161/01.CIR.0000140721.27004.4B
[Abstract]
- Coronary Heart Disease
Extracellular Matrix Changes in Stented Human Coronary Arteries
- Andrew Farb, Frank D. Kolodgie, Jin-Yong Hwang, Allen P. Burke, Kirubel Tefera, Deena K. Weber, Thomas N. Wight, and Renu Virmani
Circulation 2004;110:940-947; published online before print as doi:10.1161/01.CIR.0000139337.56084.30
[Abstract]
[Full text]
- Coronary Heart Disease
Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis: The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) Trial
- Jörg Hausleiter, Adnan Kastrati, Julinda Mehilli, Michael Vogeser, Dietlind Zohlnhöfer, Helmut Schühlen, Christoph Goos, Jürgen Pache, Franz Dotzer, Gisela Pogatsa-Murray, Josef Dirschinger, Uwe Heemann, Albert Schömig for the OSIRIS Investigators
Circulation 2004;110:790-795; published online before print as doi:10.1161/01.CIR.0000138935.17503.35
[Abstract]
[Full text]
- Coronary Heart Disease
Paclitaxel Balloon Coating, a Novel Method for Prevention and Therapy of Restenosis
- Bruno Scheller, Ulrich Speck, Claudia Abramjuk, Ulrich Bernhardt, Michael Böhm, and Georg Nickenig
Circulation 2004;110:810-814; published online before print as doi:10.1161/01.CIR.0000138929.71660.E0
[Abstract]
[Full text]
- Articles
Extracellular Matrix Changes in Stented Human Coronary Arteries
- Andrew Farb, Frank D. Kolodgie, Jin-Yong Hwang, Allen P. Burke, Kirubel Tefera, Deena K. Weber, Thomas N. Wight, and Renu Virmani
Circulation published August 9, 2004, doi:10.1161/01.CIR.0000139337.56084.30
[Abstract]
- Articles
Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis. The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) Trial
- Jörg Hausleiter, Adnan Kastrati, Julinda Mehilli, Michael Vogeser, Dietlind Zohlnhöfer, Helmut Schühlen, Christoph Goos, Jürgen Pache, Franz Dotzer, Gisela Pogatsa-Murray, Josef Dirschinger, Uwe Heemann, Albert Schömig for the OSIRIS Investigators
Circulation published August 9, 2004, doi:10.1161/01.CIR.0000138935.17503.35
[Abstract]
- Articles
Paclitaxel Balloon Coating, a Novel Method for Prevention and Therapy of Restenosis
- Bruno Scheller, Ulrich Speck, Claudia Abramjuk, Ulrich Bernhardt, Michael Böhm, and Georg Nickenig
Circulation published August 9, 2004, doi:10.1161/01.CIR.0000138929.71660.E0
[Abstract]
|
|
